Enpatoran bests placebo in improving lupus skin manifestations

Three dosing levels of enpatoran each reduced disease activity among patients with skin manifestations of cutaneous or systemic lupus erythematosus, according to data published in Lancet Rheumatology.“The connection between interferon and SLE is an old story going back to the 1970s, when Hooks and his colleagues at the NIH published in the New England Journal of Medicine the results of

Raccontata dahealio.com